The evidence for Abilify Asimtufii® in schizophrenia
Join Dr Ilan Melnick as he discusses what Abilify Asimtufii is and the evidence for its use in schizophrenia.
-
BoxBody
Abilify Asimtufii PBS Information: Authority required (STREAMLINED) Code: 16456 for Schizophrenia. This product is not listed on the PBS for the treatment of Bipolar I disorder
-
TextBody
Please review Approved Product Information before prescribing. Product Information is available here or by calling Lundbeck on 1300 721 277
Abilify Asimtufii® is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Level 2/9 Help St, Chatswood NSW 2067, Abilify Asimtufii® is co-commercialised by Lundbeck Australia Pty Ltd and Otsuka Australia Pharmaceutical Pty Ltd.
.
Related
Contributor
Dr Ilan Melnick